FDA Inspection 1154621 — Metrowest Medical Center-Framingham Campus
The FDA completed an inspection of Metrowest Medical Center-Framingham Campus on Oct 6, 2021 in Framingham, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 6, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Framingham, MA (United States)